All Stories

  1. Isolation of a multidrug-resistant Candida auris Clade V from an asymptomatic acute myeloid leukemia patient in the intensive care unit
  2. Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review
  3. Dermatophytosis in Iran: a sharp increase in cases caused by Trichophyton mentagrophytes var. indotineae
  4. Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis
  5. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  6. A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model
  7. Molecular epidemiology of dermatophytosis in Golestan, Iran: A cross-sectional study
  8. High Prevalence of Azole‐Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?
  9. Multi‐state evaluation of Candida infections in burn patients
  10. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  11. Synthesis, computational study, and antileishmanial and antifungal evaluation of phenoxyacetophenone hydrazones bearing a 4-arylthiazole moiety
  12. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  13. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  14. Caspian Sea Mycosands: The Variety and Abundance of Medically Important Fungi in Beach Sand and Water
  15. Confirmation of fifth Candida auris clade by whole genome sequencing
  16. A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of Aspergillus from Iran
  17. Five Years Surveillance Study of Clinical and Environmental Triazole‐Resistant Aspergillus fumigatus Isolates in Iran
  18. Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North‐Western Iran
  19. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis
  20. Development of RFLP method for rapid differentiation of Aspergillus flavus and Aspergillus oryzae, two species with high importance in clinical and food microbiology
  21. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  22. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole
  23. Differentiation of Aspergillus flavus from Aspergillus oryzae Targeting the cyp51A Gene
  24. In vitro antifungal activity of Thymus vulgaris essential oil nanoemulsion
  25. Diversity of Geophilic Dermatophytes Species in the Soils of Iran; The Significant Preponderance of Nannizzia fulva
  26. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  27. Galactomannan detection in bronchoalveolar lavage fluids: A diagnostic approach for fungus ball in patients with pulmonary tuberculosis?
  28. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria
  29. Relationship between spirometry results and colonisation of Aspergillus species in allergic asthma
  30. Molecular epidemiology of Tinea gladiatorum in contact sports in northern Iran
  31. <p>Emergence of Terbinafine Resistant <em>Trichophyton mentagrophytes</em> in Iran, Harboring Mutations in the Squalene Epoxidase (<em>SQLE</em>) Gene</p>
  32. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  33. Indole-derived chalcones as anti-dermatophyte agents: In vitro evaluation and in silico study
  34. Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
  35. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex
  36. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources
  37. A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly?
  38. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  39. Discrimination of Aspergillus flavus from Aspergillus oryzae by matrix‐assisted laser desorption/ionization time‐of‐flight (MALDI‐TOF) mass‐spectrometry
  40. Trichophyton mentagrophytes and T interdigitale genotypes are associated with particular geographic areas and clinical manifestations
  41. Potential Fifth Clade ofCandida auris,Iran, 2018
  42. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-offlight mass spectrometry
  43. Novel Point Mutations in cyp51A and cyp51B Genes Associated with Itraconazole and Posaconazole Resistance in Aspergillus clavatus Isolates
  44. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex
  45. Candida auris otomycosis in Iran and review of recent literature
  46. Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review
  47. Prevalence of specific immunoglobulin E and G against Aspergillus fumigatus in patients with asthma
  48. Prosthetic valve endocarditis caused by multidrug-resistant Candida albicans in a patient with myelodysplasia syndrome: A case report and literature review
  49. Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
  50. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis
  51. Molecular identification and antifungal susceptibility testing of Candida species isolated from dental plaques
  52. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies
  53. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
  54. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
  55. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  56. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
  57. Invasive forms of Candida and Aspergillus in sputum samples of pulmonary tuberculosis patients attending the tuberculosis reference laboratory in Ghaemshahr, Northern Iran: An analysis of samples collected during the past 10years
  58. Characterization of clinically important dermatophytes in North of Iran using PCR-RFLP on ITS region
  59. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays
  60. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains
  61. In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1.
  62. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma
  63. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran
  64. The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs
  65. PCR-RFLP on β-tubulin gene for rapid identification of the most clinically important species of Aspergillus
  66. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species
  67. History of treated pulmonary tuberculosis will also be an underlying symptom of opportunistic aspergillosis by Aspergillus flavus: A case report
  68. Coexistence of opportunistic mycosis and mycobacterium tuberculosis in patients attending the Central Tuberculosis Reference Laboratory of Ghaemshahr city, Iran
  69. Restriction Analysis of β-Tubulin Gene for Differentiation of the Common Pathogenic Dermatophytes
  70. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma
  71. Microsporum fulvum, an Ignored Pathogenic Dermatophyte: A New Clinical Isolation from Iran